X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (400) 400
Conference Proceeding (52) 52
Patent (36) 36
Book Review (24) 24
Publication (11) 11
Book Chapter (3) 3
Book / eBook (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (215) 215
humans (209) 209
female (132) 132
gaucher disease (132) 132
male (128) 128
adult (121) 121
enzyme replacement therapy (113) 113
hematology (107) 107
middle aged (87) 87
gaucher disease - drug therapy (86) 86
genetics & heredity (75) 75
adolescent (70) 70
gaucher disease - complications (67) 67
medicine, research & experimental (65) 65
gaucher disease - genetics (62) 62
enzymes (58) 58
aged (53) 53
child (53) 53
glucosylceramidase - therapeutic use (52) 52
glucocerebrosidase (46) 46
gaucher's disease (44) 44
imiglucerase (43) 43
treatment outcome (41) 41
child, preschool (40) 40
endocrinology & metabolism (38) 38
abridged index medicus (36) 36
glucosylceramidase - genetics (35) 35
human necessities (35) 35
hygiene (35) 35
medical or veterinary science (35) 35
preparations for medical, dental, or toilet purposes (35) 35
biochemistry & molecular biology (34) 34
genotype (34) 34
specific therapeutic activity of chemical compounds ormedicinal preparations (32) 32
gaucher disease - pathology (30) 30
mutation (30) 30
gaucher disease - blood (29) 29
young adult (28) 28
care and treatment (26) 26
gaucher disease - enzymology (25) 25
replacement therapy (25) 25
gaucher disease - diagnosis (24) 24
children (22) 22
glucosylceramidase - administration & dosage (22) 22
health aspects (22) 22
medicine, general & internal (22) 22
therapy (22) 22
gaucher disease - physiopathology (21) 21
medical research (21) 21
hemoglobin (20) 20
type-1 (20) 20
platelet count (19) 19
splenectomy (19) 19
infant (18) 18
liver (18) 18
disease (17) 17
glucosylceramidase - adverse effects (17) 17
jews - genetics (17) 17
velaglucerase alfa (17) 17
aged, 80 and over (16) 16
mutations (16) 16
severity of illness index (16) 16
diagnosis (15) 15
follow-up studies (15) 15
macrophage-targeted glucocerebrosidase (15) 15
medicine, experimental (15) 15
pediatrics (15) 15
phenotype (15) 15
animals (14) 14
gaucher disease - therapy (14) 14
recombinant proteins - therapeutic use (14) 14
spleen (14) 14
biopharmaceutics (13) 13
deficiency (13) 13
drug administration schedule (13) 13
gaucher disease - diagnostic imaging (13) 13
medicine & public health (13) 13
pregnancy (13) 13
prevalence (13) 13
registries (13) 13
retrospective studies (13) 13
adults (12) 12
anemia (12) 12
cell biology (12) 12
experience (12) 12
gaucher disease - epidemiology (12) 12
parkinson disease - genetics (12) 12
risk (12) 12
ultrasonography (12) 12
density (11) 11
enzyme replacement therapy - methods (11) 11
safety (11) 11
spleen - pathology (11) 11
substrate reduction therapy (11) 11
thrombocytopenia (11) 11
bone density - drug effects (10) 10
bones (10) 10
cells (10) 10
clinical trials (10) 10
dna mutational analysis (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2007, ISBN 9780849338168, 528 p., [8] p. of plates
Book
1997, Baillière's clinical haematology, ISBN 0702023787, Volume 10, no. 4., x, p. 621-846
Book
Blood Cells, Molecules, and Diseases, ISSN 1079-9796, 01/2011, Volume 46, Issue 1, p. 1
Journal Article
Blood Cells, Molecules and Diseases, ISSN 1079-9796, 2011, Volume 46, Issue 1, pp. 1 - 1
Journal Article
Blood Cells, Molecules, and Diseases, ISSN 1079-9796, 01/2011, Volume 46, Issue 1, p. 1
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2009, Volume 4, Issue 3, pp. e4792 - e4792
Gaucher disease is a progressive lysosomal storage disorder caused by the deficiency of glucocerebrosidase leading to the dysfunction in multiple organ... 
MULTIDISCIPLINARY SCIENCES | Recombinant Fusion Proteins - immunology | Recombinant Fusion Proteins - isolation & purification | Glucosylceramidase - genetics | Recombinant Fusion Proteins - economics | Recombinant Fusion Proteins - adverse effects | Humans | Recombinant Fusion Proteins - therapeutic use | Glucosylceramidase - adverse effects | Half-Life | Macaca fascicularis | Male | Neutralization Tests | Daucus carota - cytology | Young Adult | Clinical Trials, Phase III as Topic | Transfection | Adult | Female | Drug Evaluation, Preclinical | Gaucher Disease - drug therapy | Gaucher Disease - enzymology | Glucosylceramidase - isolation & purification | Glucosylceramidase - immunology | Cells, Cultured - enzymology | Glucosylceramidase - economics | Animals | Gaucher Disease - genetics | Glucosylceramidase - therapeutic use | Recombinant Fusion Proteins - pharmacokinetics | Antibody Formation | Infusions, Intravenous | Glucosylceramidase - pharmacokinetics | Viral antibodies | Enzymes | Biological products | Clinical trials | Primates | Antibodies | Hydrolases | Gene therapy | Drug approval | Cells | Cell culture | Intravenous administration | Disease | Science | Monkeys | Transgenic plants | Regulatory approval | Plant cells | Proteins | Toxicology | Trends | Safety | Drug dosages | Gaucher's disease | Recombinant | Immunoglobulins | Radioactive half-life | Pharmacology | FDA approval | Plants | Monkeys & apes | Studies | Hospitals | Immunogenicity | Glucosylceramidase | Laboratory animals | Pharmacokinetics | Index Medicus
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2007, Volume 29, Issue 8, pp. 1645 - 1654
Journal Article
Blood Cells, Molecules and Diseases, ISSN 1079-9796, 02/2018, Volume 68, pp. 1 - 2
Journal Article
Journal Article
Medicine & Science in Sports & Exercise, ISSN 0195-9131, 05/2017, Volume 49, p. 397
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, pp. e79732 - e79732
Journal Article
Blood Cells, Molecules and Diseases, ISSN 1079-9796, 2011, Volume 46, Issue 1, pp. 3 - 3
Journal Article
American Journal of Hematology, ISSN 0361-8609, 07/2015, Volume 90, pp. S12 - S18
Journal Article
Journal Article
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, ISSN 1422-0067, 06/2019, Volume 20, Issue 12, p. 3033
The role of glucosylsphingosine (lyso-Gb1), a downstream metabolic product of glucosylceramide, for monitoring treated and untreated children with Gaucher... 
Gaucher disease | TREATMENT-NAIVE | children | BIOCHEMISTRY & MOLECULAR BIOLOGY | glucosylsphingosine | OUTCOMES | biomarker | TYPE-1 | lyso-Gb1 | ENZYME REPLACEMENT THERAPY | CHEMISTRY, MULTIDISCIPLINARY | Spleen | Enzymes | Liver | Genotype & phenotype | Medical centres | Hemoglobin | Biomarkers | Children | Drug dosages | Age | Genotypes | Monitoring | Gaucher's disease
Journal Article
American Journal of Hematology, ISSN 0361-8609, 09/2018, Volume 93, Issue 9, pp. E246 - E248
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.